Skip to main content
Log in

Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?

  • Laboratory Investigation - Human/animal tissue
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

1p19q codeletion in WHO grade II glioma (GIIG) is claimed to be a marker of better outcome and chemosensitivity. Through the molecular study of 12 insular GIIG, our goal was to investigate a possible anatomo-molecular relationship in insula, specific brain sub-region, known to be involved with high frequency in GIIG. Loss of heterozygosity on 1p and 19q chromosomes was assessed in all tumors. None complete deletion of the 1p and 19q arms chromosomes and partial deletions in 3 patients were retrieved in the 11 WHO grade II oligodendrogliomas and one oligo-astrocytoma analyzed. Discrepancy between our results and the high reported incidence of 1p19q codeletion in oligodendrogliomas could mean that insular GIIG has a specific molecular pattern. We hypothesize that prognosis of insular GIIG is worse than in other locations, with reduced chemosensitivity. Thanks to minimization of surgical risks, surgery might be a first intention therapeutic option proposed in the GIIG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D et al (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60(3):380–383. doi:10.1002/ana.20946

    Article  PubMed  Google Scholar 

  2. Kujas M, Lejeune J, Benouaich-Amiel A, Criniere E, Laigle-Donadey F, Marie Y et al (2005) Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol 58(2):322–326. doi:10.1002/ana.20543

    Article  PubMed  CAS  Google Scholar 

  3. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E et al (2007) Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol 61(5):484–490. doi:10.1002/ana.21125

    Article  PubMed  CAS  Google Scholar 

  4. Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H et al (2004) Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 63(12):2360–2362

    PubMed  CAS  Google Scholar 

  5. Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100(12):2622–2626. doi:10.1002/cncr.20297

    Article  PubMed  Google Scholar 

  6. Duffau H, Taillandier L, Gatignol P, Capelle L (2006) The insular lobe and brain plasticity: lessons from tumor surgery. Clin Neurol Neurosurg 108(6):543–548. doi:10.1016/j.clineuro.2005.09.004

    Article  PubMed  Google Scholar 

  7. Neuloh G, Pechstein U, Schramm J (2007) Motor tract monitoring during insular glioma surgery. J Neurosurg 106(4):582–592. doi:10.3171/jns.2007.106.4.582

    Article  PubMed  Google Scholar 

  8. Yasargil M (1996) Microneurosurgery vol IVb. Georg Thieme Verlag, Stuttgart

  9. Duffau H, Capelle L, Lopes M, Faillot T, Sichez JP, Fohanno D (2000) The insular lobe: physiopathological and surgical considerations. Neurosurgery 47(4):801–810. doi:10.1097/00006123-200010000-00001 discussion 10-1

    Article  PubMed  CAS  Google Scholar 

  10. Duffau H, Gatignol P, Mandonnet E, Peruzzi P, Tzourio-Mazoyer N, Capelle L (2005) New insights into the anatomo-functional connectivity of the semantic system: a study using cortico-subcortical electrostimulations. Brain 128(Pt 4):797–810. doi:10.1093/brain/awh423

    Article  PubMed  Google Scholar 

  11. Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R et al (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76(6):845–851. doi:10.1136/jnnp.2004.048520

    Article  PubMed  CAS  Google Scholar 

  12. Duffau H, Gatignol P, Mandonnet E, Capelle L, Taillandier L Contribution of intraoperative subcortical stimulation mapping of language pathways: a consecutive series of 115 patients operated on for a WHO grade II glioma in the left dominant hemisphere. J Neurosurg (in press)

  13. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98(4):764–778

    Article  PubMed  Google Scholar 

  14. Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74(6):1784–1791 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D

    Article  PubMed  CAS  Google Scholar 

  15. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. doi:10.1093/nar/16.3.1215

    Article  PubMed  CAS  Google Scholar 

  16. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG et al (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60(21):5954–5958

    PubMed  CAS  Google Scholar 

  17. Augustine JR (1996) Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 22(3):229–244. doi:10.1016/S0165-0173(96)00011-2

    Article  PubMed  CAS  Google Scholar 

  18. Yasargil MG, von Ammon K, Cavazos E, Doczi T, Reeves JD, Roth P (1992) Tumours of the limbic and paralimbic systems. Acta Neurochir (Wien) 118(1–2):40–52. doi:10.1007/BF01400725

    Article  CAS  Google Scholar 

  19. Vanaclocha V, Saiz N, Panta F (1998) Repair of dural defects in awkward areas-technical note. Acta Neurochir (Wien) 140(6):615–618. doi:10.1007/s007010050149

    Article  CAS  Google Scholar 

  20. Zentner J, Meyer B, Stangl A, Schramm J (1996) Intrinsic tumors of the insula: a prospective surgical study of 30 patients. J Neurosurg 85(2):263–271

    PubMed  CAS  Google Scholar 

  21. Duffau H (2006) New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity—a review. J Neurooncol 79(1):77–115. doi:10.1007/s11060-005-9109-6

    Article  PubMed  Google Scholar 

  22. Lang FF, Olansen NE, DeMonte F, Gokaslan ZL, Holland EC, Kalhorn C et al (2001) Surgical resection of intrinsic insular tumors: complication avoidance. J Neurosurg 95(4):638–650

    PubMed  CAS  Google Scholar 

  23. Zlatescu MC, Tehrani Yazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN et al (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61(18):6713–6715

    PubMed  CAS  Google Scholar 

  24. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J et al (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161(1):313–319

    PubMed  CAS  Google Scholar 

  25. Mariani L, Deiana G, Vassella E, Fathi AR, Murtin C, Arnold M et al (2006) Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol 24(29):4758–4763. doi:10.1200/JCO.2006.05.9238

    Article  PubMed  CAS  Google Scholar 

  26. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145(5):1175–1190

    PubMed  CAS  Google Scholar 

  27. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90(19):1473–1479. doi:10.1093/jnci/90.19.1473

    Article  PubMed  CAS  Google Scholar 

  28. Smith JS, Perry A, Borell TJ, Lee HK, O’Fallon J, Hosek SM et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18(3):636–645

    PubMed  CAS  Google Scholar 

  29. Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F et al (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68(21):1831–1836. doi:10.1212/01.wnl.0000262034.26310.a2

    Article  PubMed  CAS  Google Scholar 

  30. Everhard S, Kaloshi G, Criniere E, Benouaich-Amiel A, Lejeune J, Marie Y et al (2006) MGMT methylation: a marker of response to temozolomide in low-grade gliomas. Ann Neurol 60(6):740–743. doi:10.1002/ana.21044

    Article  PubMed  CAS  Google Scholar 

  31. Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM et al (2003) Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 144(2):134–142. doi:10.1016/S0165-4608(02)00928-7

    Article  PubMed  CAS  Google Scholar 

  32. Mollemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G (2005) Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 113(3):379–385. doi:10.1002/ijc.20575

    Article  PubMed  CAS  Google Scholar 

  33. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M et al (2005) Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58(3):483–487. doi:10.1002/ana.20607

    Article  PubMed  CAS  Google Scholar 

  34. Taillandier L, Duffau H, Perruzi P, Fontaine D, Bauchet L, Baron M et al (2006) Who grade 2 supratentorial gliomas in adults: analysis of the prognostic factors for the optimization of the therapeutic strategy. Seventh Congress of the European Association for Neurooncology, Vienna, 14–19 September 2006. Neuro-oncology 8(15):046

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Gozé.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gozé, C., Rigau, V., Gibert, L. et al. Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?. J Neurooncol 91, 1–5 (2009). https://doi.org/10.1007/s11060-008-9680-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9680-8

Keywords

Navigation